These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 15186837)

  • 61. Different inhibitory effects of 5-S-glutathionyl-beta-alanyl-L-dopa (5-S-GA-L-D) analogues on autophosphorylation and substrate phosphorylation of Src protein tyrosine kinase.
    Zheng ZB; Nagai S; Iwanami N; Suh DY; Kobayashi A; Hijikata M; Natori S; Sankawa U
    Chem Pharm Bull (Tokyo); 1999 Jan; 47(1):136-7. PubMed ID: 9987835
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Design, synthesis, and evaluation of a novel benzamidine-based inhibitor of VEGF-C binding to Neuropilin-2.
    Said AM; Parker MW; Vander Kooi CW
    Bioorg Chem; 2020 Jul; 100():103856. PubMed ID: 32344185
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Optimization of Cyclic Plasmin Inhibitors: From Benzamidines to Benzylamines.
    Hinkes S; Wuttke A; Saupe SM; Ivanova T; Wagner S; Knörlein A; Heine A; Klebe G; Steinmetzer T
    J Med Chem; 2016 Jul; 59(13):6370-86. PubMed ID: 27280436
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Solid phase synthesis of benzamidine-derived sulfonamide libraries.
    Kim SW; Hong CY; Koh JS; Lee EJ; Lee K
    Mol Divers; 1997-1998; 3(2):133-6. PubMed ID: 9593184
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The design of phenylglycine containing benzamidine carboxamides as potent and selective inhibitors of factor Xa.
    Jones SD; Liebeschuetz JW; Morgan PJ; Murray CW; Rimmer AD; Roscoe JM; Waszkowycz B; Welsh PM; Wylie WA; Young SC; Martin H; Mahler J; Brady L; Wilkinson K
    Bioorg Med Chem Lett; 2001 Mar; 11(5):733-6. PubMed ID: 11266180
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Molecularly imprinted microgels as enzyme inhibitors.
    Cutivet A; Schembri C; Kovensky J; Haupt K
    J Am Chem Soc; 2009 Oct; 131(41):14699-702. PubMed ID: 19775079
    [TBL] [Abstract][Full Text] [Related]  

  • 67. PRO_SELECT: combining structure-based drug design and array-based chemistry for rapid lead discovery. 2. The development of a series of highly potent and selective factor Xa inhibitors.
    Liebeschuetz JW; Jones SD; Morgan PJ; Murray CW; Rimmer AD; Roscoe JM; Waszkowycz B; Welsh PM; Wylie WA; Young SC; Martin H; Mahler J; Brady L; Wilkinson K
    J Med Chem; 2002 Mar; 45(6):1221-32. PubMed ID: 11881991
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Bone-targeted 2,6,9-trisubstituted purines: novel inhibitors of Src tyrosine kinase for the treatment of bone diseases.
    Wang Y; Metcalf CA; Shakespeare WC; Sundaramoorthi R; Keenan TP; Bohacek RS; van Schravendijk MR; Violette SM; Narula SS; Dalgarno DC; Haraldson C; Keats J; Liou S; Mani U; Pradeepan S; Ram M; Adams S; Weigele M; Sawyer TK
    Bioorg Med Chem Lett; 2003 Sep; 13(18):3067-70. PubMed ID: 12941335
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Oligosaccharyltransferase inhibition induces senescence in RTK-driven tumor cells.
    Lopez-Sambrooks C; Shrimal S; Khodier C; Flaherty DP; Rinis N; Charest JC; Gao N; Zhao P; Wells L; Lewis TA; Lehrman MA; Gilmore R; Golden JE; Contessa JN
    Nat Chem Biol; 2016 Dec; 12(12):1023-1030. PubMed ID: 27694802
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Bisbenzamidines as antifungal agents. are both amidine functions required to observe an anti-Pneumocystis carinii activity?
    Laurent J; Stanicki D; Huang TL; Dei-Cas E; Pottier M; Aliouat el M; Vanden Eynde JJ
    Molecules; 2010 Jun; 15(6):4283-93. PubMed ID: 20657441
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The design, synthesis and activity of non-ATP competitive inhibitors of pp60(c-src) tyrosine kinase. Part 1: hydroxynaphthalene derivatives.
    Marsilje TH; Milkiewicz KL; Hangauer DG
    Bioorg Med Chem Lett; 2000 Mar; 10(5):477-81. PubMed ID: 10743952
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Computer based screening of compound databases: 1. Preselection of benzamidine-based thrombin inhibitors.
    Fox T; Haaksma EE
    J Comput Aided Mol Des; 2000 Jul; 14(5):411-25. PubMed ID: 10896314
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Flexible docking in solution using metadynamics.
    Gervasio FL; Laio A; Parrinello M
    J Am Chem Soc; 2005 Mar; 127(8):2600-7. PubMed ID: 15725015
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Chemistry and hypoglycemic activity of N-[[(Dialkylamino)alkoxy]phenyl]benzamidines.
    Shroff JR; Elpern B; Kobrin S; Cervoni P
    J Med Chem; 1982 Apr; 25(4):359-62. PubMed ID: 7069714
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Thrombin inhibition by novel benzamidine derivatives: a free-energy perturbation study.
    Guimarães CR; Bicca de Alencastro R
    J Med Chem; 2002 Nov; 45(23):4995-5004. PubMed ID: 12408710
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The discovery of the benzhydroxamate MEK inhibitors CI-1040 and PD 0325901.
    Barrett SD; Bridges AJ; Dudley DT; Saltiel AR; Fergus JH; Flamme CM; Delaney AM; Kaufman M; LePage S; Leopold WR; Przybranowski SA; Sebolt-Leopold J; Van Becelaere K; Doherty AM; Kennedy RM; Marston D; Howard WA; Smith Y; Warmus JS; Tecle H
    Bioorg Med Chem Lett; 2008 Dec; 18(24):6501-4. PubMed ID: 18952427
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Discovery of 3-amino-4-chlorophenyl P1 as a novel and potent benzamidine mimic via solid-phase synthesis of an isoxazoline library.
    Lam PY; Adams JJ; Clark CG; Calhoun WJ; Luettgen JM; Knabb RM; Wexler RR
    Bioorg Med Chem Lett; 2003 May; 13(10):1795-9. PubMed ID: 12729667
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A comparative QSAR study of benzamidines complement-inhibitory activity and benzene derivatives acute toxicity.
    Basak SC; Gute BD; Lucić B; Nikolić S; Trinajstić N
    Comput Chem; 2000 Mar; 24(2):181-91. PubMed ID: 10719637
    [TBL] [Abstract][Full Text] [Related]  

  • 79. 4-[3-Bromo-4-hydroxyphenyl)amino]-6,7-dimethoxyquinazolin-1-ium chloride methanol solvate and 4-[(3-hydroxyphenyl)amino]-6,7-dimethoxy-1-quinazolinium chloride.
    Ghosh S; Jennissen JD; Liu XP; Uckun FM
    Acta Crystallogr C; 2001 Jan; 57(Pt 1):76-8. PubMed ID: 11173405
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A study on the interaction between p60 c-Src receptor tyrosine kinase and arylcarboxylic and arylacetic acid derivatives based on docking modes and in vitro activity.
    Altuntas TG; Olgen S; Nebioglu D; Akaho E
    Biol Pharm Bull; 2004 Jan; 27(1):61-5. PubMed ID: 14709900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.